drugset / Trial / NCT00584896
Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine if the use of PB127 with cardiac ultrasound assists in the diagnosis or exclusion of coronary artery disease.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-07
- Completion
- 2008-07
Outcome
Outcome not reported
Stopped (Business): “Discontinued PB127 development program for business reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PB127 | Diagnostic / imaging agent | 0.062 mg/kg | Intravenous |